History
2018: Attraction of $25 million investments
For the second quarter 2018 the Israeli online service of K Health for independent diagnosis collected $25 million with the assistance of such large investors as Comcast Ventures and Mangrove Capital Partners. This amount is almost twice more, than the investments involved with the company in the first quarter 2018.
K Health is the startup specializing in primary health care and based in Tel Aviv in 2016. Its software platform considers the clinical record and clinical results of millions of patients and also experience of thousands of doctors and provides information on treatment of hundreds of diseases. By the end of December, 2018 the total amount of financing of K Health was $37.5 million.
According to the founder of a stratap, revenue received after the K Health application for smartphones steps over a threshold in 500,000 loadings (taking into account that in the application from 10,000 to 15,000 new users a day are registered) will allow it to include in the application a possibility of consultation with the virtual doctor at the beginning of 2019 and to improve the AI system of self-training. The online service is going to cooperate with doctors who will be able to hold for a certain payment consultations to users 18 years using "smart" sorting of symptoms are more senior.[1]
The set of applications (HealthTap, PlushCare, Teladoc, American Well and many others) which total cost, by estimates of some analysts, by 2022 can be $29.6 billion is presented at the perspective market of telemedicine. However the founder of K Health claims that their approach on the basis of AI in combination with use of available medical knowledge will provide to a startup necessary competitive advantages. Databases of millions of electronic medical records and 2 billion records of requests for medical care are at the disposal of K Health. All of them are provided by Maccabi, the second in value Israeli fund of health care.[2]
Notes
| The site content is translated by machine translation software powered by PROMT. The machine-translated articles are not always perfect and may contain errors in vocabulary, syntax or grammar. Read original article If you find inaccuracies or errors in the results of machine translation, please write to editor@tadviser.ru. We will make every effort to correct them as soon as possible. |